Inhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo

• Published in: Oncogene Vol. 41; no. 4; pp. 550 - 559
• Main Authors: Seo, Seung Un, Woo, Seon Min, Kim, Shin, Park, Jong-Wook, Lee, Hyun-Shik, Bae, Young-Seuk, Kim, Sang Hyun, Im, Seung-Soon, Seo, Ji Hae, Min, Kyoung-jin, Kwon, Taeg Kyu
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 21-01-2022; Nature Publishing Group
• Subjects: 13/1; 13/2; 13/31; 13/89; 14/34; 38/109; 631/67/1059/2326; 631/80/82/23; 82/29; 82/80; Animals; Antineoplastic Agents - pharmacology; Antineoplastic Agents - therapeutic use; Apoptosis; bcl-2-Associated X Protein - genetics; Casein; Casein kinase II; Cathepsin K; Cathepsin K - metabolism; Cell Biology; Cell Death; Cell Line, Tumor; Human Genetics; Humans; Internal Medicine; Kinases; Medicine; Medicine & Public Health; Mice; Mitochondria; Oncology; Oxaliplatin; Oxaliplatin - pharmacology; Oxaliplatin - therapeutic use; p53 Protein; Phosphorylation; Reactive oxygen species; Renal cell carcinoma; siRNA; Transcription; Tumor Suppressor Protein p53 - genetics; Tumors; Up-Regulation; Xenografts
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/s41388-021-02088-7

Cathepsin K is highly expressed in various types of cancers. However, the effect of cathepsin K inhibition in cancer cells is not well characterized. Here, cathepsin K inhibitor (odanacatib; ODN) and knockdown of cathepsin K (siRNA) enhanced oxaliplatin-induced apoptosis in multiple cancer cells through Bax upregulation. Bax knockdown significantly inhibited the combined ODN and oxaliplatin treatment-induced apoptotic cell death. Stabilization of p53 by ODN played a critical role in upregulating Bax expression at the transcriptional level. Casein kinase 2 (CK2)-dependent phosphorylation of OTUB1 at Ser16 played a critical role in ODN- and cathepsin K siRNA-mediated p53 stabilization. Interestingly, ODN-induced p53 and Bax upregulation were modulated by the production of mitochondrial reactive oxygen species (ROS). Mitochondrial ROS scavengers prevented OTUB1-mediated p53 stabilization and Bax upregulation by ODN. These in vitro results were confirmed by in mouse xenograft model, combined treatment with ODN and oxaliplatin significantly reduced tumor size and induced Bax upregulation. Furthermore, human renal clear carcinoma (RCC) tissues revealed a strong correlation between phosphorylation of OTUB1(Ser16) and p53/Bax expression. Our results demonstrate that cathepsin K inhibition enhances oxaliplatin-induced apoptosis by increasing OTUB1 phosphorylation via CK2 activation, thereby promoting p53 stabilization, and hence upregulating Bax.